Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227,306,614
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
55,543,085
-
Shares change
-
+3,021,753
-
Total reported value, excl. options
-
$689,284,591
-
Value change
-
+$37,297,727
-
Put/Call ratio
-
61%
-
Number of buys
-
68
-
Number of sells
-
-37
-
Price
-
$12.41
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q3 2020
140 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q3 2020.
Gossamer Bio, Inc. - Common Stock (GOSS) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55,543,085 shares
of 227,306,614 outstanding shares and own 24% of the company stock.
Largest 10 shareholders include HILLHOUSE CAPITAL ADVISORS, LTD. (7,420,974 shares), VANGUARD GROUP INC (4,710,062 shares), Capital International Investors (4,643,561 shares), BlackRock Inc. (4,639,624 shares), Omega Fund Management, LLC (3,320,608 shares), BOXER CAPITAL, LLC (2,562,358 shares), Artal Group S.A. (2,358,968 shares), ALLIANCEBERNSTEIN L.P. (2,308,314 shares), STATE STREET CORP (2,154,989 shares), and FEDERATED HERMES, INC. (2,019,037 shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.